(Q73101615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

main subject

acute myeloid leukemia

1 reference

1 reference

6

Blazar BR

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Baker KS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Bostrom B

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

DeFor T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ramsay NK

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Woods WG

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

607-614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11041565%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702590

1 November 2019

exact match

0 references

cites work

Pretransplant conditioning with busulfan (Myleran) and cyclophosphamide for nonmalignant diseases. Assessment of engraftment following histocompatible allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Marrow transplantation for thalassaemia following busulphan and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Aspects concerning busulfan pharmacokinetics and bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Pharmacokinetics of high-dose busulfan in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

1 reference

7 January 2021

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Graft-Versus-Host Disease: Pathophysiological and Clinical Aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021

Growth after bone marrow transplantation in young children conditioned with chemotherapy alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702590

7 January 2021